Sandoz Group AGXSWX:SDZ -1.20%11 Return-on-Tangible-Asset is 8.82% as of Dec. 2025, which is 18% above its 10-year median of 7.49. GuruFocus rates XSWX:SDZ with a GF Score™ of 11/100. The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Sandoz Group AG ranks better than 69.85% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sandoz Group AG's annualizedNet Income for the quarter that ended in Dec. 2025 was CHF856 Mil. Sandoz Group AG's average total tangible assets for the quarter that ended in Dec. 2025 was CHF9,700 Mil. Therefore, Sandoz Group AG's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 8.82%.
The historical rank and industry rank for Sandoz Group AG's Return-on-Tangible-Asset or its related term are showing as below:
XSWX:SDZ'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.79 Med: 7.49 Max: 9.79
Current: 7.55
During the past 4 years, Sandoz Group AG's highest Return-on-Tangible-Asset was 9.79%. The lowest was 0.79%. And the median was 7.49%.
XSWX:SDZ's Return-on-Tangible-Asset is ranked better than 69.85% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 3.17
vs XSWX:SDZ: 7.55
Sandoz Group AG (XSWX:SDZ) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sandoz Group AG Return-on-Tangible-Asset Related Terms
Sandoz Group AG Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Sandoz Group AG's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SDZ vs ZTS, UTHR, VTRS: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sandoz Group AG Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sandoz Group AG's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 8.82% mean?
Sandoz Group AG (XSWX:SDZ) has a Return-on-Tangible-Asset of 8.82% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sandoz Group AG and its competitors. This is 18% above median its historical median of 7.49. Over the past decade, Sandoz Group AG's Return-on-Tangible-Asset has ranged from 0.79 to 9.79. According to the industry distribution chart, Sandoz Group AG ranks #303 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 30.1%.
Is Sandoz Group AG's Return-on-Tangible-Asset too high?
Sandoz Group AG's current Return-on-Tangible-Asset of 8.82% is 18% above median its 10-year median of 7.49. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 9.79. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.17. Sandoz Group AG's value of 8.82% is 178.2% above this industry median. Based on the distribution chart, Sandoz Group AG ranks #303 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Sandoz Group AG has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sandoz Group AG ranks #303 out of 1005 companies for Return-on-Tangible-Asset. This puts Sandoz Group AG in the upper half of its industry. The industry median Return-on-Tangible-Asset is 3.17. Sandoz Group AG's value of 8.82% is 178.2% above this benchmark. Historically, Sandoz Group AG's own Return-on-Tangible-Asset has ranged from 0.79 to 9.79 over the past decade. While the company's 10-year median is 7.49 vs. the industry median of 3.17, Sandoz Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.17, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sandoz Group AG's current Return-on-Tangible-Asset of 8.82% is 178.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sandoz Group AG and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sandoz Group AG's current Return-on-Tangible-Asset is 8.82%, which is 18% above median its own 10-year median of 7.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (XSWX:SDZ) has a current Return-on-Tangible-Asset of 8.82%. The current Return-on-Tangible-Asset is 8.82%, which is 18% above median its 10-year median of 7.49 and 178.2% above the Drug Manufacturers industry median of 3.17. Sandoz Group AG's overall GF Score™ is 11/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sandoz Group AG (XSWX:SDZ), the current Return-on-Tangible-Asset is 8.82% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
11GF Score
Get the complete analysis for XSWX:SDZ
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SDZ has been successfully added to your 